Abstract
Introduction: The CYP2D6 gene encodes a cytochrome P450 enzyme responsible for the metabolism of approximately 20% of clinically used drugs, including antineoplastics and opioids. Genetic variations in this gene influence the metabolic phenotype, allowing individuals to be classified as poor, intermediate, normal, or ultrarapid metabolizers. The analysis of copy number variations (CNVs) i…